isoxazoles has been researched along with mycophenolic acid in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (21.33) | 18.2507 |
| 2000's | 31 (41.33) | 29.6817 |
| 2010's | 28 (37.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, N; Weidemann, MJ | 1 |
| Groth, CG; Karlsson-Parra, A; Korsgren, O; Liu, J; Rafael, E; Sundberg, B; Tibell, A; Wallgren, AC; Wennberg, L; Zhu, S | 1 |
| Antoniou, E; D'Silva, M; DeRoover, A; Howie, A; McMaster, P; Nishimura, Y | 1 |
| Halloran, PF | 1 |
| Brazelton, TR; Morris, RE | 1 |
| Antoniou, E; D'Silva, M; DeRoover, A; Howie, AJ; McMaster, P; Nishimura, Y | 1 |
| Hausen, B; Morris, RE | 1 |
| Biberfeld, P; Groth, CG; Karlsson-Parra, A; Korsgren, O; Liu, J; Morris, RE; Rafael, E; Söderlund, J; Tibell, A; Wennberg, L; Zhu, S | 1 |
| Waer, M | 1 |
| Antoniou, EA; Chondros, K; D'Silva, M; Howie, A; McMaster, P; Xu, M | 1 |
| Gregory, CR | 1 |
| Fung, JJ; Goller, A; Miki, T; Rao, A; Starzl, TE; Tandin, A; Valdivia, LA; Wang, X; Yin, WY | 1 |
| Bonham, CA; Gerber, DA; Thomson, AW | 1 |
| Gross, WL | 1 |
| Gummert, JF; Ikonen, T; Morris, RE | 1 |
| Furst, DE | 1 |
| Bari, S; Groth, CG; Korsgren, O; Song, Z; Sundberg, B; Wennberg, L; Wijkström, M; Zhang, J | 1 |
| Bari, S; Bennet, W; Groth, CG; Korsgren, O; Nava, S; Song, Z; Sundberg, B; Wennberg, L; Zhang, J | 2 |
| Craigmill, AL; Gregory, CR; Kyles, AE | 1 |
| Dambrin, C; Klupp, J; Morris, RE | 1 |
| Ambach, A; Konstandin, M; Meuer, SC; Samstag, Y; Saunus, J; Wesselborg, S | 1 |
| Kallenberg, CG; Stegeman, CA; Tervaert, JW | 1 |
| Albert, R; Andersen, E; Floersheim, P; Hungerford, V; Papageorgiou, C; Schreier, MH; Zurini, M | 1 |
| Wallace, D | 1 |
| Abu-Shakra, M; Buskila, D | 1 |
| Drosos, AA | 1 |
| Drakulic, D; Miljkovic, Dj; Samardzic, T; Stosic-Grujicic, S; Trajkovic, V | 1 |
| Brennan, DC; Hardinger, KL; Jendrisak, MD; Lowell, JA; Miller, BW; Schnitzler, MA; Shenoy, S; Wang, CD | 1 |
| Frieling, U; Luger, TA | 1 |
| Kushwaha, SS; Mayer, DF | 1 |
| Fischer, M; Ott, P; Schläpfer, E; Speck, RF | 1 |
| Chira, P; Sandborg, CI | 1 |
| Deuse, T; Reichenspurner, H; Schrepfer, S | 1 |
| Heath, M; Raugi, GJ | 1 |
| Casadio, F; Corti, B; Croci, S; D'Errico Grigioni, A; Grigioni, WF; Landuzzi, L; Lollini, PL | 1 |
| Gross, WL; Hellmich, B; Lamprecht, P | 1 |
| de Groot, K; Jayne, D | 1 |
| Birnbaum, F; Reinhard, T; Reis, A; Scholz, C; Schwartzkopff, J | 1 |
| Burton, JM; O'Connor, P | 1 |
| McHugh, NJ; Soriano, ER | 1 |
| Becker, J; Bowman, J; Davison, J; Douglas, C; Gauvin, D; Hu, W; Huang, LY; Jiang, B; Kauffman, S; Li, Y; Martel, N; Rahkhoodaee, F; Ransom, T; Rodriguez-Suarez, R; Roemer, T; Sillaots, S; Trosok, S; Veillette, K; Wang, H; Xu, D; Youngman, P; Zhang, L | 1 |
| Hsu, CJ; Wang, LF | 1 |
| Böhler, T; Canivet, C; Galvani, S; Gandia, P; Guilbeau-Frugier, C; Kamar, N; Mengelle, C; Negre-Salvayre, A; Rostaing, L; Salvayre, R; Thomsen, M | 1 |
| Hiemstra, TF; Jayne, D | 1 |
| Dickenmann, M; Egli, A; Hirsch, HH; Köhli, S | 1 |
| Karjalainen, A; Pettersson, T | 1 |
| Li, DM; Liu, XW; Sun, SR; Xu, GS | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| First, MR; Fitzsimmons, W; Guasch, A; Holman, J; Roy-Chaudhury, P; Woodle, ES | 1 |
| Egli, A; Helmersen, DS; Hirsch, HH; Johnson, A; Taub, K | 1 |
| Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
| Hoppe-Seyler, F; Hoppe-Seyler, K; Lohrey, C; Sauer, P | 1 |
| Artifoni, M; Puéchal, X | 1 |
| Baliga, P; Bratton, C; Chavin, K; Krisl, JC; McGillicuddy, J; Pilch, N; Taber, DJ; Thomas, B | 1 |
| Lei, T; Liu, G; Peng, J; Sun, C; Wang, R; Wu, T; Xu, K; Zhang, L; Zhao, Y | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Krämer, BK; Ostrowski, M; Squifflet, JP; Vanrenterghem, Y; Wlodarczyk, Z | 1 |
| Chen, D; Hu, X; Li, L; Ma, Y; Mao, Z; Mei, C; Sun, L; Xie, G; Xu, C; Xu, J; Yang, L; Ye, C; Zhao, X | 1 |
| Alexander, SR; Chaudhuri, A; Chen, SF; Concepcion, W; Grimm, P; McClellan, RB; Nguyen, L | 1 |
| Ehrenhofer-Murray, AE; Franke, J; Stephan, J | 1 |
| Bartsch, M; Effelsberg, NM; Hässler, F; Hentze, C; Miehle, N; Peter, HH; Salzer, U; Schlesier, M; Sic, H; Thiel, J; Venhoff, N; Voll, RE; Warnatz, K | 1 |
| Feldman, BM; Gross, WL; Guillevin, L; Hazlewood, GS; Metzler, C; Pagnoux, C; Tomlinson, GA | 1 |
| Foley, P; Kelly, JB; Strober, BE | 1 |
| Chan, TM | 1 |
| Bao, H; Chen, YH; Hu, WX; Liu, ZH; Liu, ZZ; Wang, SF; Zhang, HT | 1 |
| Moroni, G; Ponticelli, C | 1 |
| Baughman, RP; Lower, EE | 1 |
| Furie, R; Toder, K; Zapantis, E | 1 |
| Chen, Y; Liu, Z; Wang, J; Xu, F; Zeng, C | 1 |
| Cagnoli, GA; Cassina, M; Clementi, M; Di Gianantonio, E; Zuccarello, D | 1 |
| Craig, JC; Hodson, EM; Willis, NS; Wong, SC | 1 |
| Cook, L; Foulke, L; J Conti, D; Keys, B; Lopez-Soler, RI; Stellrecht, K; Yang, D | 1 |
| Archer, TM; Mackin, AJ; Thomason, JM; Wills, RW | 1 |
37 review(s) available for isoxazoles and mycophenolic acid
| Article | Year |
|---|---|
Molecular mechanisms of new immunosuppressants.
Topics: Amino Acid Isomerases; B-Lymphocytes; Biphenyl Compounds; Calcineurin; Calmodulin-Binding Proteins; Carrier Proteins; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Isoxazoles; Leflunomide; Mycophenolic Acid; Oxidoreductases; Peptidylprolyl Isomerase; Phosphoprotein Phosphatases; Polyenes; Purines; Pyrimidines; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; T-Lymphocytes; Tacrolimus | 1996 |
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
Topics: Animals; Autoimmune Diseases; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Polyenes; Pyrimidine Nucleotides; Sirolimus; Tacrolimus; Xenobiotics | 1996 |
Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies.
Topics: Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Transplantation; Lymphatic Irradiation; Methotrexate; Mycophenolic Acid; Photopheresis; Polyenes; Recurrence; Sirolimus; Tacrolimus | 1997 |
New immunosuppressive agents for organ transplantation.
Topics: Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Nitriles; Organ Transplantation; Polyenes; Sirolimus; Tacrolimus | 1997 |
Immunosuppressive approaches to the prevention of graft vascular disease.
Topics: Coronary Disease; Cyclosporine; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Polyenes; Postoperative Complications; Sirolimus; Tacrolimus | 1998 |
Immunosuppressive agents: recent developments in molecular action and clinical application.
Topics: Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Models, Biological; Mycophenolic Acid; Polyenes; Ribonucleosides; Sirolimus; T-Lymphocytes; Tacrolimus; Transplantation Immunology | 1998 |
New concepts in treatment protocols for severe systemic vasculitis.
Topics: Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Vasculitis | 1999 |
Newer immunosuppressive drugs: a review.
Topics: Animals; Clinical Trials as Topic; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Sirolimus; Tacrolimus | 1999 |
Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Arthritis, Rheumatoid; Enzyme Inhibitors; Humans; Isoxazoles; Leflunomide; Metalloendopeptidases; Mycophenolic Acid | 1999 |
Pharmacodynamics of immunosuppressive drugs.
Topics: Animals; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Sirolimus; Tacrolimus | 2000 |
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antilymphocyte Serum; Cyclophosphamide; Guanidines; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Isoxazoles; Kidney Diseases; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisone; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Vasculitis | 2001 |
Current and emerging lupus treatments.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Dehydroepiandrosterone; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Mycophenolic Acid; Oligonucleotides | 2001 |
Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.
Topics: Animals; Arthritis, Rheumatoid; Cyclosporine; Cytokines; Gene Expression Regulation; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mitogen-Activated Protein Kinases; Mycophenolic Acid; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Sirolimus; Tacrolimus | 2002 |
Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.
Topics: Administration, Oral; Autoimmune Diseases; Female; Fertility; Fetal Death; Humans; Immunosuppressive Agents; Infertility, Male; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Pregnancy; Skin Diseases | 2002 |
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome | 2003 |
Novel therapies in pediatric rheumatic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Child; Genetic Therapy; Humans; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Neoplasm Proteins; Receptors, Tumor Necrosis Factor, Type II; Rheumatic Diseases; Rituximab; Sialoglycoproteins; Stem Cell Transplantation; Tumor Necrosis Factor Decoy Receptors | 2003 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Advances in the therapy of Wegener's granulomatosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Etanercept; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Receptors, Tumor Necrosis Factor; Recurrence; Rituximab | 2006 |
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisolone; Receptors, Tumor Necrosis Factor; Vasculitis | 2005 |
Novel oral agents for multiple sclerosis.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cladribine; Clinical Trials as Topic; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Isoxazoles; Leflunomide; Minocycline; Multiple Sclerosis; Mycophenolic Acid; Propylene Glycols; Pyridones; Quinolones; Sphingosine | 2007 |
Conventional therapy of psoriatic arthritis: evidence-based review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Sulfasalazine; Treatment Outcome | 2007 |
Emerging treatment of atopic dermatitis.
Topics: Androstadienes; Animals; Dermatitis, Atopic; Desensitization, Immunologic; Fluticasone; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukotriene Antagonists; Mycophenolic Acid; T-Lymphocytes, Regulatory | 2007 |
Newer therapies for vasculitis.
Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Plasma Exchange; Stem Cell Transplantation; Treatment Outcome; Vasculitis | 2009 |
[Diagnosis and management of small vessel vasculitides].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Progression; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Vasculitis | 2010 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
How to treat refractory arthritis in lupus?
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis; Azathioprine; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoconjugates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2012 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
Topics: Adult; Alkylating Agents; Calcineurin Inhibitors; China; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Tacrolimus | 2012 |
Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome | 2014 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
Immunosuppression in pregnant women with systemic lupus erythematosus.
Topics: Contraindications; Cyclosporine; Female; Glucocorticoids; Humans; Hypertension; Immunosuppression Therapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Maternal Exposure; Mycophenolic Acid; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Withholding Treatment | 2015 |
Treatment of Sarcoidosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Clinical Trials as Topic; Drug Administration Schedule; Granuloma; Humans; Immunologic Factors; Infliximab; Isoxazoles; Leflunomide; Lung; Methotrexate; Mycophenolic Acid; Prednisone; Respiratory Function Tests; Sarcoidosis; Skin; Tomography, X-Ray Computed | 2015 |
Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Boron Compounds; Bortezomib; Clinical Trials as Topic; Drug Discovery; Glycine; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Off-Label Use; Oligonucleotides; Quinolones; Recombinant Fusion Proteins; Rituximab; Tacrolimus; Treatment Outcome | 2015 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dexamethasone; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Isoxazoles; Leflunomide; Mycophenolic Acid; Nephrotic Syndrome; Prednisone; Randomized Controlled Trials as Topic; Remission Induction | 2016 |
JC polyomavirus nephropathy, a rare cause of transplant dysfunction: Case report and review of literature.
Topics: Biopsy; BK Virus; Creatinine; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Isoxazoles; JC Virus; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Nephritis; Polymerase Chain Reaction; Polyomavirus Infections; Sirolimus; Tacrolimus; Transplantation, Homologous; Viremia | 2017 |
4 trial(s) available for isoxazoles and mycophenolic acid
| Article | Year |
|---|---|
Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Nephrotic Syndrome; Prednisone; Treatment Outcome; Young Adult | 2010 |
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.
Topics: Algorithms; Alkynes; Creatinine; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Mycophenolic Acid; Nitriles; Patient Compliance; Polyomavirus Infections; Sirolimus; Tacrolimus; Time Factors; Viral Load | 2010 |
A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation.
Topics: Adult; Alkynes; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Nitriles; Steroids; Tacrolimus | 2012 |
Effects of immunosuppressive agents on the hemostatic system in normal dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azathioprine; Blood Coagulation; Blood Platelets; Creatinine; Cross-Over Studies; Cyclosporine; Dogs; Female; Hemostasis; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Platelet Aggregation; Platelet Count; Prednisone; Thromboxane B2 | 2018 |
34 other study(ies) available for isoxazoles and mycophenolic acid
| Article | Year |
|---|---|
Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
Topics: Alanine; Cell Differentiation; Cell Division; Formates; Hematopoiesis; Humans; Hypoxanthine; Hypoxanthines; In Vitro Techniques; Inosine Monophosphate; Isoxazoles; Leukemia, Myeloid; Mycophenolic Acid; Phosphoribosyl Pyrophosphate; Purines; Pyrimidines; Reactive Oxygen Species; Tumor Cells, Cultured | 1995 |
Immunosuppression with cyclosporin A in combination with leflunomide and mycophenolate mofetil prevents rejection of pig-islets transplanted into rats.
Topics: Animals; Antibodies, Heterophile; Cyclosporine; Drug Therapy, Combination; Fetal Tissue Transplantation; Graft Rejection; Immunoglobulin G; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 1996 |
Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
Topics: Animals; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Tacrolimus; Transplantation, Homologous; Transplantation, Isogeneic | 1996 |
Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival.
Topics: Animals; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rats; Rats, Inbred Lew; Tacrolimus; Transplantation, Homologous | 1996 |
Triple drug treatment with cyclosporine, leflunomide and mycophenolate mofetil prevents rejection of pig islets transplanted into rats and primates.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Haplorhini; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 1997 |
Combination treatment effectively intercepts advanced acute cardiac rejection.
Topics: Animals; Biphenyl Compounds; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous; Transplantation, Isogeneic | 1997 |
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
Topics: Animals; Cyclophosphamide; Drug Synergism; Graft Survival; Guinea Pigs; Immunosuppressive Agents; Isoxazoles; Leflunomide; Liver Transplantation; Mycophenolic Acid; Rats; Rats, Inbred Lew; Survival Rate; Tacrolimus; Transplantation, Heterologous | 1998 |
Efficacy of malononitriloamide 279 and 715 in islet xenotransplantation: a study in the pig-to-rat model.
Topics: Alkynes; Animals; Cyclosporine; Drug Therapy, Combination; Fetal Tissue Transplantation; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Mycophenolic Acid; Nitriles; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 2000 |
Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Topics: Animals; Blood Glucose; Cyclosporine; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 2000 |
Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
Topics: Animals; Cats; Cell Division; Coloring Agents; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Immunosuppressive Agents; Inhibitory Concentration 50; Isoxazoles; Leflunomide; Lymphocyte Activation; Mycophenolic Acid; Pokeweed Mitogens; Scintillation Counting; Sirolimus; Tacrolimus; Trypan Blue | 2000 |
The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.
Topics: Actin Depolymerizing Factors; Cyclosporine; Dexamethasone; Humans; Isoxazoles; Leflunomide; Microfilament Proteins; Mycophenolic Acid; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Sirolimus; T-Lymphocytes; Tacrolimus | 2000 |
Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Topics: Animals; Antibodies, Heterophile; Blood Glucose; C-Peptide; Cell Culture Techniques; Cell Separation; Cyclosporine; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Female; Graft Survival; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Macrophages; Mice; Mice, Nude; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 2001 |
Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.
Topics: Aniline Compounds; Animals; Antigens, Heterophile; B-Lymphocytes; Biphenyl Compounds; Cell Division; Crotonates; Cyclosporine; Drug Resistance; Graft Rejection; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Lymphoma, B-Cell; Mycophenolic Acid; Nitriles; Primates; Pyrazoles; Swine; T-Lymphocytes; Toluidines; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Update on the treatment of systemic lupus erythematosus: therapeutic highlights from the Sixth International Lupus Conference.
Topics: Antimalarials; Biological Therapy; Congresses as Topic; Cyclophosphamide; Dehydroepiandrosterone; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Mycophenolic Acid | 2002 |
Immunosuppressants leflunomide and mycophenolic acid inhibit fibroblast IL-6 production by distinct mechanisms.
Topics: Aniline Compounds; Animals; Cell Line; Cell Survival; Cells, Cultured; Coloring Agents; Crotonates; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Guanidines; Humans; Hydroxybutyrates; Immunosuppressive Agents; Interferon-gamma; Interleukin-6; Isoxazoles; Leflunomide; Macrophages; Mice; Mycophenolic Acid; Nitric Oxide Synthase; Nitriles; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Rolipram; Tetrazolium Salts; Thiazoles; Time Factors; Toluidines | 2002 |
Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction.
Topics: Adult; Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Mycophenolic Acid | 2002 |
Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; DNA, Viral; Dose-Response Relationship, Drug; Drug Combinations; Flow Cytometry; HIV-1; Humans; Hydroxyurea; Isoxazoles; Leflunomide; Leukocytes, Mononuclear; Mycophenolic Acid | 2003 |
Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model.
Topics: Alkynes; Animals; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Models, Animal; Mycophenolic Acid; Nitriles; Rats; Transplantation, Homologous | 2003 |
Toward the definition of immunosuppressive regimens with antitumor activity.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Jurkat Cells; Leflunomide; Liver Neoplasms; Mycophenolic Acid; Rhabdomyosarcoma; Sirolimus | 2005 |
The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
Topics: Alkynes; Animals; Cornea; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Keratoplasty, Penetrating; Mycophenolic Acid; Nitriles; Postoperative Care; Postoperative Period; Rats; Rats, Inbred F344; Rats, Inbred Lew; Survival Analysis; Treatment Outcome | 2007 |
Mechanism-of-action determination of GMP synthase inhibitors and target validation in Candida albicans and Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Carbon-Nitrogen Ligases; Diazooxonorleucine; Drug Resistance, Fungal; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; IMP Dehydrogenase; Isoxazoles; Microbial Sensitivity Tests; Mycophenolic Acid; Purines; Ribonucleosides | 2007 |
Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.
Topics: Adult; Aged; Antigens, CD; BK Virus; Cell Proliferation; Disease Progression; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Nephritis; Polyomavirus Infections; Receptors, Transferrin; T-Lymphocytes; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Immunosuppressants: JC virus encephalopathy. Rare but fatal.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antirheumatic Agents; Humans; Immunosuppressive Agents; Isoxazoles; JC Virus; Leflunomide; Leukoencephalopathy, Progressive Multifocal; Mycophenolic Acid; Natalizumab; Rituximab; Sirolimus; Tacrolimus | 2009 |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs.
Topics: Adult; Aged; BK Virus; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Isoxazoles; Kidney Transplantation; Leflunomide; Middle Aged; Mycophenolic Acid; Polyomavirus Infections; Reference Values; T-Lymphocytes; Tacrolimus | 2009 |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy.
Topics: Adult; Aged; Cidofovir; Cytosine; Female; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Organophosphonates; Polyomavirus Infections; Prednisone; Renal Insufficiency; Tacrolimus; TOR Serine-Threonine Kinases | 2010 |
The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro.
Topics: Alkynes; Cells, Cultured; Enzyme Inhibitors; HEK293 Cells; Hep G2 Cells; Hepatitis B virus; Humans; Immunosuppressive Agents; In Vitro Techniques; Isoxazoles; Leflunomide; Mycophenolic Acid; Nitriles; Real-Time Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Virus Replication | 2012 |
Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.
Topics: Adult; Aniline Compounds; Antiviral Agents; Biotransformation; BK Virus; Chi-Square Distribution; Crotonates; Drug Monitoring; Female; Humans; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Nitriles; Polymerase Chain Reaction; Polyomavirus Infections; Proportional Hazards Models; Retrospective Studies; South Carolina; Toluidines; Treatment Outcome; Tumor Virus Infections; Viral Load | 2012 |
Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
Topics: Adoptive Transfer; Animals; CD4-Positive T-Lymphocytes; Cell Count; Cyclophosphamide; Cyclosporine; Fingolimod Hydrochloride; Forkhead Transcription Factors; Immune Tolerance; Immunity; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Isoxazoles; Leflunomide; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Mycophenolic Acid; Ovalbumin; Propylene Glycols; Sirolimus; Sphingosine; Spleen; T-Lymphocytes, Regulatory | 2012 |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients.
Topics: Adolescent; Antiviral Agents; Child; Drug Substitution; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Molluscum Contagiosum; Mycophenolic Acid; Skin Diseases, Viral; Tacrolimus; Treatment Outcome; Warts | 2012 |
Chemical genetic screen in fission yeast reveals roles for vacuolar acidification, mitochondrial fission, and cellular GMP levels in lifespan extension.
Topics: Dynamins; Garcinia mangostana; Guanosine Monophosphate; Hydroxybenzoates; Indoles; Isoxazoles; Mitochondrial Dynamics; Monensin; Mycophenolic Acid; Nigericin; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Schizosaccharomyces; Schizosaccharomyces pombe Proteins; Time Factors; Vacuolar Proton-Translocating ATPases; Vacuoles | 2013 |
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; B-Lymphocyte Subsets; Cyclophosphamide; Female; Homeostasis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Rituximab | 2013 |
Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lupus Nephritis; Male; Mycophenolic Acid; Nephrotic Syndrome; Podocytes; Prednisone; Proteinuria; Remission Induction; Retrospective Studies; Tacrolimus; Treatment Outcome | 2015 |
Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients.
Topics: Adolescent; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Anti-Inflammatory Agents; China; Female; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Hematuria; Humans; Hypertension; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Phytotherapy; Plant Preparations; Prednisone; Prognosis; Proteinuria; Recurrence; Renal Insufficiency; Retrospective Studies; Tacrolimus; Tripterygium; Young Adult | 2016 |
Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fetal Diseases; Fetus; Fluconazole; Humans; Isoxazoles; Leflunomide; Mutation; Mycophenolic Acid; Phenotype; Pregnancy; Teratogenesis; Teratogens; Thalidomide; Warfarin | 2017 |